Human Growth Peptides Ipamorelin for Regulation of Body Weight 170851-70-4

• Post Date:

  May 10,2017

• Expiry Date:

  May 10,2018

• Detailed Description:

  Cas No. :170851-70-4 Quantity: 10Kilograms
  Specs:Formula: C38H49N9O5
  Price:100 USD Kilograms
  Payment Method: T/T,monay gram,western union
  Human Growth Peptides Ipamorelin for Regulation of Body Weight 170851-70-4
   
  Quick Detail:
  Ipamorelin
  Ipamorelin Alias : 696: PN:WO2004005342 PAGE: 46 claimed protein, Ipamorelin, NNC 26-0161
  Ipamorelin CAS: 170851-70-4
  Ipamorelin Formula: C38H49N9O5
  Ipamorelin MW:711.853
  Ipamorelin Appearance: White powder
  Ipamorelin Grade : Pharmaceutical Grade
  Ipamorelin purity:99%min
  Ipamorelin Usage :Growth hormone secretagogue receptor is a G protein-coupled receptorthat binds ghrelin and plays a role in energy homeostasis and regulation of bodyweight.
  
   contact me:trust@ycgmp.com  whats app:+8618826123740
   
  Description:
  Ipamorelinis a fascinating new muscle building discovery that is getting a lot of attention in the bodybuilding world. Like the GHRP-6 peptide (growth hormone releasing hexapeptide), it is a synthetic peptide that has powerful Growth Hormone releasing properties. And these GH releasing properties are what is of interest to athletes and bodybuilders since they can make a tremendous difference in the amount of muscle you can grow and how quickly you burn fat.
  
   
  Human Growth Peptides Ipamorelin for Regulation of Body Weight 170851-70-4
   
  Applications:
  Ipamorelin is an interesting peptide taken 300mcg twice daily or you could lower the dose for 3 times daily, side effects are head rushs, I would recommend taking this 30 minutes before workout ,with gear, Ipamorelin is a new and potent synthetic pentapeptide which has distinct and specific growth hormone (GH)-releasing properties. With the objective of investigating the effects on longitudinal bone growth rate , body weight , and GH release, Ipamorelin in different doses (0, 18, 90 and 450 μg/day) was injected three times daily for 15 days to test subjects, After intravital Tetracycline labelling on days 0, 6, and 13, LGR was determined by measuring the distance between the respective fluorescent bands in the proximal tibia metaphysis. Ipamorelin dose-dependently increased LGR from 42 μm/day in the vehicle group to 44, 50, and 52 μm/day in the treatment groups . There was also a pronounced and dose-dependent effect on body weight gain. The treatment did not affect total IGF-I levels, or serum markers of bone formation and resorption. The number of tartrate-resistant acid phosphatase-positive multinuclear cells in the metaphysis of the tibia did not change significantly with treatment. The responsiveness of the pituitary to a provocative i.v. dose of Ipamorelin or GHRH showed that the plasma GH response was marginally reduced , after Ipamorelin, but unchanged after GHRH. The pituitary GH content was unchanged by Ipamorelin treatment. Whether Ipamorelin or other GH secretagogues may have a place in the treatment of children with growth retardation requires demonstration in future clinical studies. Before closing Ipamorelin is the most selective GH releaser you can get.
  

• CAS Registry Number:

  170851-70-4

• Synonyms:

  Ipamorelin [INN];2-Methylalanyl-L-histidyl-3-(2-naphthyl)-D-alanyl-D-phenylalanyl-L-lysinamide;UNII-Y9M3S784Z6;2-Methylalanyl-L-histidyl-3-(2-naphthyl)-D-alanyl-D-phenylalanyl-L-lysinamide.;2-methylalanyl-L-histidyl-3-naphthalen-2-yl-D-alanyl-D-phenylalanyl-L-lysinamide;

• Molecular Formula:

  C₃₈H₄₉N₉O₅

• Molecular Weight:

  711.853

• Molecular Structure:

  

• Company:

  Guangzhou Huao Chemical Co. Ltd     [ China ]        

• Contact:

  Abby

• Tel:

  +8618826123740

• Fax:

• Email:

  trustful@ycgmp.com